152 related articles for article (PubMed ID: 6548420)
1. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Wils J; Schlangen J; Naus A
Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Wils J; Schlangen J; Naus A
Recent Results Cancer Res; 1986; 100():157-62. PubMed ID: 3755539
[No Abstract] [Full Text] [Related]
3. Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II study.
Theodors A; Bukowski RM; Lavery I; Hewlett JS; Livingston RB; Buonocore E
Med Pediatr Oncol; 1982; 10(5):463-70. PubMed ID: 6183567
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery infusion chemotherapy for colorectal metastases: a personal experience.
Donegan WL
J Surg Oncol; 1985 Nov; 30(3):177-83. PubMed ID: 2934584
[TBL] [Abstract][Full Text] [Related]
5. Effect of adriamycin, 5-fluorouracil and mitomycin-C combination chemotherapy in advanced colorectal cancer.
Stathopoulos GP; Stergiou GS; Golematis B; Thalassinos N; Fillipakis M
Oncology; 1995; 52(4):306-9. PubMed ID: 7777244
[TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
Weder W; Roethlin M; Metzger U; Largiadèr F
Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
10. [The effect and CT imaging of FAM hepatic infusion chemotherapy in patients with liver metastasis from colorectal carcinoma].
Aoki T; Arai Y; Kido C; Endo T; Sato Y; Ozawa H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2744-8. PubMed ID: 3631974
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of a phase II study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer].
Arai Y; Kido C; Endo T; Aoki T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2327-33. PubMed ID: 3606152
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Cohen AM; Schaeffer N; Higgins J
Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
[TBL] [Abstract][Full Text] [Related]
13. [Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
Sakurai Y; Kodaira S; Teramoto T; Miyajima N; Kuzuoka M; Ishii T; Arisawa Y; Takabayashi T; Abe O
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2473-8. PubMed ID: 3415258
[TBL] [Abstract][Full Text] [Related]
14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic artery 5-fluorouracil and mitomycin-C in previously untreated patients with hepatic metastases from colorectal carcinoma.
Cowan JD; Easterbrock J; Mills GM; McCracken JD
Mil Med; 1982 Mar; 147(3):220-3. PubMed ID: 6806715
[No Abstract] [Full Text] [Related]
16. Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK).
Borner M; Laffer U; Ludwig C; Obrist R; Metzger U; Aeberhard P; Weber W; Castiglione M; Obrecht JP; Brunner K
Ann Oncol; 1990; 1(3):227-8. PubMed ID: 2261369
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
18. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
19. [Clinical observations of hepatic artery infusion therapy combined with hepatic artery ligation in metastatic liver cancers].
Kin R; Iwamori S; Saeki S; Nishimawari K; Akiyama H; Nagusa Y; Sasao T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):661-5. PubMed ID: 3128181
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
